KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)

Elanco Animal Health's Asset Writedowns and Impairment history spans 9 years, with the latest figure at $47.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 840.0% year-over-year to $47.0 million; the TTM value through Dec 2025 reached $91.0 million, up 75.0%, while the annual FY2025 figure was $71.0 million, 12.35% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $47.0 million at Elanco Animal Health, up from $24.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $275.0 million in Q2 2021 and bottomed at $5.0 million in Q4 2021.
  • The 5-year median for Asset Writedowns and Impairment is $23.0 million (2022), against an average of $45.8 million.
  • The largest annual shift saw Asset Writedowns and Impairment soared 9066.67% in 2021 before it plummeted 81.48% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $5.0 million in 2021, then skyrocketed by 1080.0% to $59.0 million in 2022, then plummeted by 54.24% to $27.0 million in 2023, then crashed by 81.48% to $5.0 million in 2024, then surged by 840.0% to $47.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Asset Writedowns and Impairment are $47.0 million (Q4 2025), $24.0 million (Q3 2025), and $5.0 million (Q4 2024).